The direct immunofluorescence assay (DFA) was compared with culture for test-of-cure analysis for Chlamydia trachomatis in patients 7 to 10 days after antimicrobial therapy was given. DFA test-of-cure results correlated with culture results in 79.5% of 39 patients. Of DFA-negative patients, 97% had negative cultures. Six of seven patients with borderline DFA results had negative culture results.
Since the introduction of the direct immunofluorescence assay (DFA) for Chlamydia trachomatis in genital tract specimens (8) , numerous studies have shown that direct testing is highly sensitive and specific (3, 5, 7, 8) compared with culture isolation methods. Culture methods may be indicated to verify patient compliance with antimicrobial therapy and to ensure effective therapy for infection. Although the DFA has proven useful for the detection of infection, there are no data on the use of this test as a test of cure (TOC) . Therefore, the purpose of this study was to compare the MicroTrak DFA (Syva Co., Palo Alto, Calif.) with isolation by cell culture as a TOC in female patients seen in our Family Planning Clinic 7 to 10 days after the cessation of appropriate antimicrobial therapy.
The study was done in the Family Planning Clinic at the Hospital of the University of Pennsylvania. The prevalence of chlamydial infection in the population in this study was approximately 14% based on culture results from our hospital laboratory. The prevalence of gonococcal infection in this population has been studied previously and was 6.9% (4) . Patients seen in the clinic for their routine gynecologic examination or for diagnosis of a suspected sexually transmitted disease were tested. They were given a pelvic examination by either a nurse practitioner or a physician, and two swabs were collected for testing at that time. Although the specimens were not routinely collected in any particular order, specimen 1 was generally collected for DFA, and specimen 2 was collected for culture. We used the MicroTrak Direct Test For a patient to be eligible for this study, both the DFA and culture results from the initial visit had to be positive. After the results were available, a patient with a positive DFA and culture was recalled to the clinic to receive the appropriate antimicrobial therapy, and an appointment was scheduled for TOC testing. Except for one patient treated with erythromycin, 500 mg four times a day for 10 days, all of the patients received doxycycline, 100 mg two times a day for 7 days (1). Several patients had also received ampicillin and probenecid for concomitant gonococcal infections. TOC testing was done 7 to 10 days after the end of antimicrobial therapy.
During the study period, 866 patients were screened for chlamydial infection. Of these patients, 13.7% (119 patients) had chlamydial infections as defined by a positive DFA and culture test; 63% (75 patients) returned for follow-up visits, with 32.7% (39 patients) returning within the 7-to 10-day period after cessation of antimicrobial therapy for TOC analysis. Table 1 shows the TOC results of 39 patients 
